Bastian Schmack

Bastian M. Schmack is a German lawyer (Rechtsanwalt) since 2018, who devotes most of his work to private equity and venture capital clients.

Bastian focuses his practice on private equity and M&A deals, including distressed M&A, management equity participations as well as venture capital, covering all assets classes but in particular life sciences, tech and real estate. He also delivers advice to a broad range of clients on general corporate and employment matters.

Before joining Goodwin, Bastian practiced for three years as an associate at another international law firm in Frankfurt for which he had earlier also clerked as a legal trainee in New York City.

His recent experience includes representing:

• PATRIZIA Alternative Investments on their administration of several real estate portfolios*
• Deutsche Beteiligungs AG on its acquisition of a majority in Frimo Group GmbH, one of the world's leading suppliers of molds and equipment for the production of plastic components for various applications*
• An investor on the sale of a majority participation in a Premier League football club*
• International Campus on the set-up of a EUR 600 million funds and various transactions concerning student housing accommodations in Europe*
• Multinational cinema group on the intended acquisition of the German group of a competitor*
• German PE firm capiton on the acquisition of Hamm Reno Group and on its joint venture with CCC S.A.*
• Gerry Weber AG on its restructuring during its insolvency proceedings*
• BioLabs on the launch of BioLabs|TUM, a new biotechnology innovation hub in central Munich, in partnership with TUM Venture Labs and Eli Lilly and Company
• LoginVSI BV on acquisition of Hydra
• SpringWorks Therapeutics Inc in its definitive agreement to be acquired by Merck KGaA at an equity value of approximately $3.9 billion
• Zealand Pharma in connection with partnership with Roche worth up to $5.3 billion to co-develop and co-commercialize Petrelintide monotherapy and combination products in the U.S. and Europe as therapy for obesity
• Teleflex Incorporated (NYSE:TFX) in its definitive agreement to acquire substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG for an estimated cash payment on closing of approximately €760 million
• Veganz Group AG in connection with the restructuring of its listed EUR 10m bearer bond
• Forterro Group on the acquisition of software company ORGADATA AG
• Minority shareholders of Frankfurt based LifeFit Group on the sale to private equity company Waterland
• TA Associates on its strategic growth investment in SER, a global Intelligent Content Automation software vendor
• Consortium RE-Think in connection with the bidding process for insolvent GALERIA Karstadt Group
• Heidelberg Pharma AG, a clinical stage biotech company developing innovative Antibody Drug Conjugates, on its royalty financing agreement with Healthcare Royalty
• Piva Capital as lead investor in the €90 million (US$129 million) Series B financing round of INERATEC GmbH
• Novo Holdings in connection with investment into Booster Therapeutics GmbH
• Prime Footwear Investors AG on the acquisition and financing of the footwear retailers Salamander and Klauser
• Ocean 14 Capital in connection with investment into Goodcarbon GmbH
• Cionix on the sale of its hosting business to dogado
• Swiss Prime on the acquisition of various senior care homes
• FIZZ Student Housing SCS on the sale of a portfolio consisting of five student apartment buildings in Germany and Austria to International Campus Group
• Veganz on acquisition of an exclusive licence for printed dairy products from Vitiprints
• Veracode on the acquisition of Crashtest Security Solution
• Triton on the sale of dogado to Cinven and OTPP
• app smart GmbH in connection with its merger with OrderYOYO of Denmark
• Veganz on a strategic cooperation with Aramark
• Real estate company Cofinimmo on its €39 million acquisition of three retirement and nursing homes
• Veganz Group AG on all corporate law issues related to the implementation and structuring of its IPO
• The management as co-investors of Garz & Fricke Holding GmbH, in the sale of their stake in Garz & Fricke to (and re-investment into) Italian listed company SECO S.p.A.
• German “Bundesliga” football club on equity financings
• The vegan food company Veganz Group AG on raising €11m from Brandenburg Kapital in a second tranche of equity financing
• Capital Bay Group on the formation of a joint venture with UAE-based Gulf Islamic Investments LLC

*Denotes experience prior to joining Goodwin.

Prior to joining Goodwin in 2021, Bastian practiced as an Associate at Allen & Overy LLP in Frankfurt for three years (2018 – 2021).

Before his admission as a German lawyer (Rechtsanwalt) in 2018, Bastian worked as part of his legal clerkship at Allen & Overy LLP in Frankfurt and New York City. From 2010 until 2016 and parallel to his legal studies with specialization in business law, Bastian has also gained experience as an legal research assistant at other international law firms such as Linklaters LLP.